TY - JOUR T1 - <span hwp:id="article-title-1" class="article-title">7 Juvenile idiopathic arthritis</span><span hwp:id="article-title-2" class="sub-article-title">7.1 Changes of antioxidative status and free radical damage in subsets of juvenile idiopathic arthritis (JIA) over a period of three months</span><span hwp:id="article-title-3" class="sub-article-title">7.2 Growth disturbances in patients with juvenile idiopathic arthritis (JIA): Has the prevalence changed?</span><span hwp:id="article-title-4" class="sub-article-title">7.3 Study of IL6, TNF, and IFNγ in the serum of patients with juvenile idiopathic arthritis and systemic lupus erythematosus</span><span hwp:id="article-title-5" class="sub-article-title">7.4 Referral of children with JRA by general paediatricians</span><span hwp:id="article-title-6" class="sub-article-title">7.5 Infection associated MAS in 3 patients receiving ASCT for refractory JIA</span><span hwp:id="article-title-7" class="sub-article-title">7.6 Modern point of view on juvenile rheumatoid arthritis with uveitis</span><span hwp:id="article-title-8" class="sub-article-title">7.7 Tumour necrosis factor and its soluble receptors in activation of the autoimmune process in patients with juvenile rheumatoid arthritis</span><span hwp:id="article-title-9" class="sub-article-title">7.8 Nutritional aspects in juvenile chronic arthritis</span><span hwp:id="article-title-10" class="sub-article-title">7.9 Macrophage activation syndrome in childhood rheumatic diseases: a tertiary hospital experience</span><span hwp:id="article-title-11" class="sub-article-title">7.10 An evidence base for uveitis screening in juvenile idiopathic arthritis</span><span hwp:id="article-title-12" class="sub-article-title">7.11 Juvenile idiopathic arthritis and related autoimmune diseases</span><span hwp:id="article-title-13" class="sub-article-title">7.12 Prevalence of iridocyclitis in juvenile idiopathic arthritis</span><span hwp:id="article-title-14" class="sub-article-title">7.13 Systemic juvenile idiopathic arthritis associated with Kikuchi's disease</span><span hwp:id="article-title-15" class="sub-article-title">7.14 Cardiac manifestations in systemic juvenile idiopathic arthritis</span><span hwp:id="article-title-16" class="sub-article-title">7.15 Neurosensorial loss of hearing in systemic idiopathic juvenile arthritis</span><span hwp:id="article-title-17" class="sub-article-title">7.16 Pulmonary hypertension in systemic juvenile idiopathic arthritis</span><span hwp:id="article-title-18" class="sub-article-title">7.17 Temporomandibular synovitis as a unique presentation of juvenile idiopathic arthritis</span><span hwp:id="article-title-19" class="sub-article-title">7.18 Intestinal pseudo-obstruction due to amyloidosis in a child with juvenile idiopathic arthritis</span><span hwp:id="article-title-20" class="sub-article-title">7.19 Detachment of the anterior cruciate ligament: a potential misdiagnosis using MRI of juvenile idiopathic arthritis (JIA) beginning as gonarthritis</span><span hwp:id="article-title-21" class="sub-article-title">7.20 Prognostic role of antinuclear antibodies in juvenile idiopathic arthritis</span><span hwp:id="article-title-22" class="sub-article-title">7.21 Importance of the synovial fluid aspiration before injecting intra-articular corticosteroids</span><span hwp:id="article-title-23" class="sub-article-title">7.22 Ultrasound of the knee: diagnostic value in juvenile idiopathic arthritis</span><span hwp:id="article-title-24" class="sub-article-title">7.23 Genetic component in juvenile idiopathic arthritis</span><span hwp:id="article-title-25" class="sub-article-title">7.24 Significance of raised serological markers of coeliac disease in children with juvenile rheumatoid arthritis</span><span hwp:id="article-title-26" class="sub-article-title">7.25 Differentiation between acute lymphocytic leukaemia (ALL) and juvenile idiopathic arthritis (JIA)</span><span hwp:id="article-title-27" class="sub-article-title">7.26 ANA detection by recombinant antigens in juvenile idiopathic arthritis and connectivitis</span><span hwp:id="article-title-28" class="sub-article-title">7.27 Health related quality of life (HRQoL) of children with juvenile idiopathic arthritis (JIA)</span><span hwp:id="article-title-29" class="sub-article-title">7.28 Serum ferritin (SF) and serum glycosylated ferritin (SGF) evaluation in systemic juvenile rheumatic diseases in childhood</span> JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - 729 LP - 734 DO - 10.1136/ard.59.9.729 VL - 59 IS - 9 AU - B FINCKH AU - PJ HASHKES AU - D MIHAYLOVA AU - L STEIN AU - DMC BRINKMAN AU - S SALOUGINA AU - L OMELCHENKO AU - L RONDINONE AU - S SAWHNEY AU - C MACHADO AU - MG ALPIGIANI AU - M CERBONI AU - SKF OLIVEIRA AU - SKF OLIVEIRA AU - SKF OLIVEIRA AU - SKF OLIVEIRA AU - G MARTINI AU - L LEPORE AU - H MICHELS AU - M BARDARE AU - I CALVO AU - I CALVO AU - A SAVOLAINEN AU - S M AL-MAYOUF AU - O JONES AU - U SANDINI-POHJAVUORI AU - I FOELDVARI AU - S COMPEYROT AU - I FOELDVARI AU - M MEHRWALD AU - D HUELSEBUS AU - A KOHLSCHÜTTER AU - DJ LOVELL AU - I BOYKINOV AU - D NIKOLOVA AU - N IVANOVA AU - K LISITCHKI AU - S STEFANOV AU - V GENOVA AU - S CLARK AU - G FREED AU - S KAMPHUIS AU - P QUARTIER AU - AM PRIEUR AU - R TEN CATE AU - M BIERINGS AU - NM WULFFRAAT AU - N KUZMINA AU - A SHAIKOV AU - V CHERNYSHOV AU - I DUDKA AU - T LJUDVIK AU - T POCHINOK AU - M VODYANIK AU - V NIKOLAJENKO AU - E VYKHOVANETS AU - L GALLITELLI AU - F FANTINI AU - V GERLONI AU - P WOO AU - KJ MURRAY AU - C BENTLEY AU - V LEE AU - E GRAHAM AU - K MURRAY AU - P WOO AU - C EDELSTEN AU - M CERBONI AU - T MUSTICA AU - A IESTER AU - R LORINI AU - MG ALPIGIANI AU - R DE MARCO AU - T MUSTICA AU - P VITTONE AU - A IESTER AU - UBW DESTRI AU - LCO VASQUEZ AU - S FERMAN AU - S ROMANO AU - FR SZTAJNBOK AU - LG GUEDES, JR CARVALHO AU - AECL PALHARES AU - S KNUPP AU - AFGS MARQUES AU - LL CAMPOS AU - AFG SILVA AU - M RODRIGUES AU - FR STANJBOK AU - ACM MARQUES AU - C DOMINGUES AU - M RODRIGUES AU - FA MALTA NETO AU - U BACCILIERO AU - A TREGNAGHI AU - F ZULIAN AU - S FACCHINI AU - C MALORGIO AU - A VENTURA AU - L SCHUCHMANN AU - M SCARAZATTI AU - V MARTINI AU - A GRASSI AU - A PETACCIA AU - L LACRUZ AU - L LACRUZ AU - H SÄILÄ AU - K KOTANIEMI AU - O KAIPIAINEN-SEPPÄNEN AU - M LEIRISALO-REPO AU - K AHO AU - A ALMEHAIDIB AU - M ALKAFF AU - S BAHABRI AU - E RABINOVICH AU - S BOWYER AU - P DENT AU - N ILOWITE AU - C SPENCER AU - ET AL AU - V AUBERT AU - P ROUX-LOMBARD AU - J-J CHESEAUX AU - M HOFER AU - M REDEGELD AU - M MEHRWALD AU - D HÜLSEBUS AU - M BULLINGER AU - P QUARTIER AU - G LE MOEL AU - G CHÈDEVILLE AU - AM PRIEUR Y1 - 2000/09/01 UR - http://ard.bmj.com/content/59/9/729.abstract N2 - 7.1 Changes of antioxidative status and free radical damage in subsets of juvenile idiopathic arthritis (JIA) over a period of three monthsJIA is an inflammatory disease in which the role of free radicals has not yet been clarified. We recently showed a specific pattern of antioxidative status and free radical damage in subsets of JIA.1 We investigated whether this pattern is characteristic for subsets of disease or inflammatory activity.Patients (n=85) with JIA were seen consecutively in the paediatric rheumatology unit during one year and again after three months. The disease subsets were: oligoarticular juvenile rheumatoid arthritis (oJRA, n=54), polyarticular JRA (pJRA, n=3), systemic JRA (sJRA, n=4), spondyloarthritis (SA, n=18), and psoriatic arthritis (n=6). Patients with non-inflammatory joint pain served as controls (n=15). Erythrocyte sedimentation rate (ESR), in vitro radical resistance of erythrocytes (RRE), total radical trapping ability of plasma (TRAP), malondialdehyde as marker of lipid peroxidation, sulphydryl (SH) groups, and α-tocopherol as antioxidants were analysed in blood.According to the JIA subsets, the following differences were seen between the first and second visit: a decrease in the tender joint score in patients with oJRA (p&lt;0.001) corresponding with an increase of α-tocopherol (p&lt;0.05) and TRAP (p&lt;0.01). All patients with JIA were stratified according to inflammatory disease activity into groups with low (&lt;20 mm/1st h), medium (20–40 mm/1st h), and high ESR (&gt;40 mm/1st h). The differences seen between these groups and controls during the first visit (increase of in vitro RRE (high ESR); and decrease in SH groups (medium ESR)) were not seen again during the second visit.The increase in antioxidative potential and simultaneous decrease of tender joint score in patients with oJRA underline the role of antioxidants in JIA. It remains to be elucidated whether the change of pattern according to inflammatory disease activity means that there is no characteristic reproducible pattern of antioxidative status and free radical damage in relation to inflammatory disease activity.1-1.(1999) Arthritis Rheum 42(suppl):S181, .OpenUrl7.2 Growth disturbances in patients with juvenile idiopathic arthritis (JIA): Has the prevalence changed?Previous studies have … ER -